Back
VYNE Therapeutics Stock Predictions
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Buy
60
VYNE
VYNE Therapeutics
Last Price:
2.98
Seasonality Move:
-9.41%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeVYNE Therapeutics Stock Forecast
-
Is VYNE Therapeutics Stock Undervalued?
The current VYNE Therapeutics [VYNE] share price is $2.91. The Score for VYNE is 60, which is 20% above its historic median score of 50, and infers lower risk than normal. - VYNE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will VYNE Therapeutics Stock Go Up Next Year?
Data Unavailable
VYNE Therapeutics Stock Rating
Data Unavailable
VYNE Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
vynetherapeutics.com
52-Week Data
52-Week High:
4.48
52-Week Low:
1.57
Prediction Charts
Market Cap:
42.92M
Price in USD:
2.91
Volume:
110.15K
Beta:
1.47
Technical Analysis
SMA50:
2.24
SMA100:
2.07
SMA200:
2.24
52-Wk Change:
-16.38%
Stock Predictions
-
Is VYNE Therapeutics stock public?
Yes, VYNE Therapeutics is a publicly traded company. -
What is the VYNE Therapeutics stock quote today?
The VYNE Therapeutics stock price is 2.91 USD today. -
How to buy VYNE Therapeutics stock online?
You can buy VYNE Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-25 | 2.67 | 2.67 | 2.79 | 2.62 |
| Oct-28 | 2.75 | 2.84 | 2.85 | 2.69 |
| Oct-29 | 2.84 | 2.70 | 2.84 | 2.60 |
| Oct-30 | 2.71 | 2.75 | 2.80 | 2.70 |
| Oct-31 | 2.74 | 2.72 | 2.74 | 2.57 |
| Nov-1 | 2.74 | 2.65 | 2.74 | 2.61 |
| Nov-4 | 2.69 | 2.99 | 3.14 | 2.62 |
| Nov-5 | 3.01 | 3.28 | 3.30 | 2.96 |
| Nov-6 | 3.38 | 3.13 | 3.43 | 3.05 |
| Nov-7 | 3.13 | 3.16 | 3.30 | 3.12 |
| Nov-8 | 3.15 | 3.16 | 3.25 | 3.11 |
| Nov-11 | 3.21 | 3.02 | 3.21 | 2.90 |
| Nov-12 | 2.99 | 2.99 | 3.02 | 2.86 |
| Nov-13 | 3.00 | 2.91 | 3.05 | 2.90 |
VYNE Therapeutics Earnings
Data Unavailable
VYNE Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and a decrease next year of $1.05 per share.
* VYNE Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.